It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Vaccines stand out as one of the most effective tools in our arsenal for reducing morbidity and mortality. Nonetheless, public hesitancy towards vaccination often stems from concerns about potential side effects, which can vary from person to person. As of now, there are no automated systems available to proactively warn against potential side effects or gauge their severity following vaccination. We have developed machine learning (ML) models designed to predict and detect the severity of post-vaccination side effects. Our study involved 2111 participants who had received at least one dose of either a COVID-19 or influenza vaccine. Each participant was equipped with a Garmin Vivosmart 4 smartwatch and was required to complete a daily self-reported questionnaire regarding local and systemic reactions through a dedicated mobile application. Our XGBoost models yielded an area under the receiver operating characteristic curve (AUROC) of 0.69 and 0.74 in predicting and detecting moderate to severe side effects, respectively. These predictions were primarily based on variables such as vaccine type (influenza vs. COVID-19), the individual's history of side effects from previous vaccines, and specific data collected from the smartwatches prior to vaccine administration, including resting heart rate, heart rate, and heart rate variability. In conclusion, our findings suggest that wearable devices can provide an objective and continuous method for predicting and monitoring moderate to severe vaccine side effects. This technology has the potential to improve clinical trials by automating the classification of vaccine severity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Tel-Aviv University, Department of Industrial Engineering, Tel-Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546)
2 Stanford University, Department of Management Science and Engineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)
3 Tel-Aviv University, Department of Industrial Engineering, Tel-Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546); MIT Media Lab, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786)
4 Tel-Aviv University, Department of Industrial Engineering, Tel-Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546); Stanford University, Department of Management Science and Engineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Tel-Aviv University, Center for Combatting Pandemics, Tel-Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546)